The most advanced line
of Hyaluronic Acid dermal fillers

About Genefill

Experienced doctors and medical professionals have meticulously designed all Genefill products, ensuring natural outcomes and ease of application

Each of Genefill products is formulated using cross-linked or non-cross-linked hyaluronic acid derived from non-animal sources, aiming to create a radiant appearance and provide optimal hydration. These qualities work synergistically to enhance skin quality and maintain its vitality over the long term.

The Genefill product range consists of a wide selection of biphasic dermal fillers designed for both the face and body, targeting multiple skin layers. This line of products is specifically tailored to meet the demands of even the most discerning patients, offering the ability to achieve well-defined contours, lift and add volume to the skin, and effectively reduce the appearance of fine lines and wrinkles.

About BioScience

BioScience GmbH is a German manufacturer designing and producing medical devices based on hyaluronic acid.

As of today, they are one of the few manufacturers to offer both monophasic and biphasic dermal fillers.

Committed to helping people in maintaining a youthful appearance and ultimately improving their overall quality of life.

Our knowledge and experience have brought us the trust of the most recognized plastic surgeons and dermatologists worldwide.

Biphasic Dermal Fillers

Biphasic fillers, widely being used for face rejuvenation and body augmentation, are known for delivering favorable outcomes in both volume enhancement and long-lasting effects.

The reason behind their extended durability lies in the fact that biphasic fillers take longer to be broken down (or degraded) by the body.


Thanks to its advanced technology, Genefill dermal fillers have one of the lowest residual BDDE particles in their composition,  presenting a toxicity level lower than the more strictest standards around the world.

FDA allowed amount of Residual BDDE (EU) less than 0.0002 mg
Standards Amount of Residual BDDE (Genefill) less than 0.0001 mg

Having significantly lower toxicity has successfully demonstrated BDDE as one of the safest cross-linking agents to stabilize the HA-based dermal fillers in the industry.

Additionally, BDDE is also biodegradable making it much preferred for biomedical applications, especially cosmetic products.
*Disclaimer: Before any dermal filler treatment, we recommend asking your doctor about the product, crosslinking agents, and toxicity level.
Are you a Healtcare professional?